Enanta Pharmaceuticals, Inc. · NASDAQ:ENTA

Deep Track Capital, LP reported a 6.78% stake in Enanta Pharmaceuticals, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 13, 2026

Deep Track Capital, LP reported a 6.78% stake in Enanta Pharmaceuticals, Inc., 1,956,867 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).

Stake
6.78%
Shares
1,956,867
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP6.78%1,956,867
Deep Track Biotechnology Master Fund, Ltd.6.78%1,956,867
David Kroin6.78%1,956,867

Source

View original at SEC

Related